Bringing real innovation to Medicare

Forbes April 17, 2019
Dan Mendelson

While politicians debate the feasibility of Medicare-for-all and other broad-stroke policy, all eyes in the health policy world are focused on a more specific, but arguably more dramatic, decision that the Centers for Medicare and Medicaid Services (CMS) is making right now. A new study on Transcatheter Aortic Valve Replacement (TAVR) for the treatment of severe aortic stenosis (SSAS) showed that this procedure is safer and more effective than older ways of treating patients with open heart surgery.¹ And CMS is deciding how and when it should be covered – and in so doing – how to disrupt the old ways of doing things and bring real innovation to Medicare patients.

The science is fascinating and impressive. TAVR is a...

Today's Sponsors

Today's Sponsor